Funds and ETFs Regeneron Pharmaceuticals, Inc.
Equities
REGN
US75886F1075
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
883.2 USD | -0.84% | -1.52% | +0.56% |
04-26 | Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says | MT |
04-26 | Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125 | MT |
ETFs positioned on Regeneron Pharmaceuticals, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.27% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - | |
4.02% | 1 M€ | -5.79% | - | |
2.56% | 8 M€ | +2.44% | ||
1.90% | 18 M€ | +3.79% | - | |
1.85% | 2 M€ | +6.77% | ||
1.65% | 9 M€ | -4.31% | - | |
1.62% | 2 M€ | -25.75% | ||
1.33% | 26 M€ | +16.85% | - | |
1.13% | 9 M€ | +15.45% | - | |
1.06% | 1 M€ | 0.00% | - | |
1.02% | 16 M€ | -8.49% | ||
1.02% | 1,182 M€ | +1.06% | ||
1.01% | 1 M€ | +16.32% | ||
1.00% | 204 M€ | +10.54% | ||
0.94% | 11 M€ | -6.03% | - | |
0.79% | 10 M€ | +5.96% | ||
0.78% | 282 M€ | +3.59% | - | |
0.77% | 9 M€ | -.--% | - | |
0.74% | 92 M€ | +0.06% | - | |
0.72% | 22 M€ | 0.00% | - | |
0.72% | 5 M€ | -72.95% | - | |
0.71% | 3 M€ | 0.00% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.56% | 95.28B | |
-2.31% | 103B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B | |
-24.71% | 8.24B |
- Stock Market
- Equities
- REGN Stock
- Funds and ETFs Regeneron Pharmaceuticals, Inc.